+
Open data
-
Basic information
| Entry | ![]() | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Title | Coxsackievirus A9 bound with compound 19 (CL313) | ||||||||||||
Map data | Density map of Coxsackievirus A9 bound with compound 19 (CL313) obtained by cryoEM and single-particle processing in cryoSPARC at global resolution 2.69 A. | ||||||||||||
Sample |
| ||||||||||||
Keywords | Antiviral / capsid stabilizer / hydrophobic pocket / cryoEM / VIRUS | ||||||||||||
| Function / homology | Function and homology informationsymbiont-mediated suppression of host cytoplasmic pattern recognition receptor signaling pathway via inhibition of RIG-I activity / picornain 2A / symbiont-mediated suppression of host mRNA export from nucleus / symbiont genome entry into host cell via pore formation in plasma membrane / picornain 3C / T=pseudo3 icosahedral viral capsid / host cell cytoplasmic vesicle membrane / nucleoside-triphosphate phosphatase / channel activity / monoatomic ion transmembrane transport ...symbiont-mediated suppression of host cytoplasmic pattern recognition receptor signaling pathway via inhibition of RIG-I activity / picornain 2A / symbiont-mediated suppression of host mRNA export from nucleus / symbiont genome entry into host cell via pore formation in plasma membrane / picornain 3C / T=pseudo3 icosahedral viral capsid / host cell cytoplasmic vesicle membrane / nucleoside-triphosphate phosphatase / channel activity / monoatomic ion transmembrane transport / DNA replication / RNA helicase activity / endocytosis involved in viral entry into host cell / symbiont-mediated activation of host autophagy / RNA-directed RNA polymerase / cysteine-type endopeptidase activity / viral RNA genome replication / RNA-directed RNA polymerase activity / DNA-templated transcription / virion attachment to host cell / host cell nucleus / structural molecule activity / ATP hydrolysis activity / proteolysis / RNA binding / zinc ion binding / ATP binding / membrane Similarity search - Function | ||||||||||||
| Biological species | Human coxsackievirus A9 (strain Griggs) / Coxsackievirus A9 | ||||||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 2.69 Å | ||||||||||||
Authors | Plavec Z / Butcher SJ / Mitchell C / Buckner C | ||||||||||||
| Funding support | Finland, 3 items
| ||||||||||||
Citation | Journal: J Med Chem / Year: 2024Title: SAR Analysis of Novel Coxsackie virus A9 Capsid Binders. Authors: Chiara Tammaro / Zlatka Plavec / Laura Myllymäki / Cristopher Mitchell / Sara Consalvi / Mariangela Biava / Alessia Ciogli / Aušra Domanska / Valtteri Leppilampi / Cienna Buckner / Simone ...Authors: Chiara Tammaro / Zlatka Plavec / Laura Myllymäki / Cristopher Mitchell / Sara Consalvi / Mariangela Biava / Alessia Ciogli / Aušra Domanska / Valtteri Leppilampi / Cienna Buckner / Simone Manetto / Pietro Sciò / Antonio Coluccia / Mira Laajala / Giulio M Dondio / Chiara Bigogno / Varpu Marjomäki / Sarah J Butcher / Giovanna Poce / ![]() Abstract: Enterovirus infections are common in humans, yet there are no approved antiviral treatments. In this study we concentrated on inhibition of one of the (EV-B), namely Coxsackievirus A9 (CVA9), using ...Enterovirus infections are common in humans, yet there are no approved antiviral treatments. In this study we concentrated on inhibition of one of the (EV-B), namely Coxsackievirus A9 (CVA9), using a combination of medicinal chemistry, virus inhibition assays, structure determination from cryogenic electron microscopy and molecular modeling, to determine the structure activity relationships for a promising class of novel -phenylbenzylamines. Of the new 29 compounds synthesized, 10 had half maximal effective concentration (EC) values between 0.64-10.46 μM, and of these, 7 had 50% cytotoxicity concentration (CC) values higher than 200 μM. In addition, this new series of compounds showed promising physicochemical properties and act through capsid stabilization, preventing capsid expansion and subsequent release of the genome. | ||||||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_50617.map.gz | 168.4 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-50617-v30.xml emd-50617.xml | 23.5 KB 23.5 KB | Display Display | EMDB header |
| FSC (resolution estimation) | emd_50617_fsc.xml | 14.8 KB | Display | FSC data file |
| Images | emd_50617.png | 64 KB | ||
| Filedesc metadata | emd-50617.cif.gz | 7.4 KB | ||
| Others | emd_50617_half_map_1.map.gz emd_50617_half_map_2.map.gz | 319.2 MB 319.2 MB | ||
| Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-50617 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-50617 | HTTPS FTP |
-Validation report
| Summary document | emd_50617_validation.pdf.gz | 1.1 MB | Display | EMDB validaton report |
|---|---|---|---|---|
| Full document | emd_50617_full_validation.pdf.gz | 1.1 MB | Display | |
| Data in XML | emd_50617_validation.xml.gz | 24.3 KB | Display | |
| Data in CIF | emd_50617_validation.cif.gz | 31.8 KB | Display | |
| Arichive directory | https://ftp.pdbj.org/pub/emdb/validation_reports/EMD-50617 ftp://ftp.pdbj.org/pub/emdb/validation_reports/EMD-50617 | HTTPS FTP |
-Related structure data
| Related structure data | ![]() 9fo5MC ![]() 8s7jC ![]() 9exiC ![]() 9fa9C ![]() 9fczC ![]() 9fgnC ![]() 9fo2C ![]() 9fp5C M: atomic model generated by this map C: citing same article ( |
|---|---|
| Similar structure data | Similarity search - Function & homology F&H Search |
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|---|
| Related items in Molecule of the Month |
-
Map
| File | Download / File: emd_50617.map.gz / Format: CCP4 / Size: 347.6 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Density map of Coxsackievirus A9 bound with compound 19 (CL313) obtained by cryoEM and single-particle processing in cryoSPARC at global resolution 2.69 A. | ||||||||||||||||||||||||||||||||||||
| Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 0.97 Å | ||||||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-Half map: Half map of Coxsackievirus A9 bound with compound...
| File | emd_50617_half_map_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Half map of Coxsackievirus A9 bound with compound 19 (CL313) obtained by cryoEM and single-particle processing in cryoSPARC. | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: Half map of Coxsackievirus A9 bound with compound...
| File | emd_50617_half_map_2.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | Half map of Coxsackievirus A9 bound with compound 19 (CL313) obtained by cryoEM and single-particle processing in cryoSPARC. | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-
Sample components
-Entire : Coxsackievirus A9
| Entire | Name: Coxsackievirus A9 |
|---|---|
| Components |
|
-Supramolecule #1: Coxsackievirus A9
| Supramolecule | Name: Coxsackievirus A9 / type: virus / ID: 1 / Parent: 0 / Macromolecule list: #1-#4 Details: Coxsackievirus A9 was propagated on green monkey kidney cells and purified on a sucrose gradient. NCBI-ID: 12067 / Sci species name: Coxsackievirus A9 / Sci species strain: Griggs / Virus type: VIRION / Virus isolate: STRAIN / Virus enveloped: No / Virus empty: No |
|---|---|
| Host (natural) | Organism: Homo sapiens (human) |
| Molecular weight | Theoretical: 8 MDa |
| Virus shell | Shell ID: 1 / Name: icosahedral capsid / Diameter: 300.0 Å / T number (triangulation number): 1 |
-Macromolecule #1: Capsid protein VP1
| Macromolecule | Name: Capsid protein VP1 / type: protein_or_peptide / ID: 1 / Number of copies: 1 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Human coxsackievirus A9 (strain Griggs) |
| Molecular weight | Theoretical: 33.86902 KDa |
| Sequence | String: GDVEEAIERA VVHVADTMRS GPSNSASVPA LTAVETGHTS QVTPSDTMQT RHVKNYHSRS ESTVENFLGR SACVYMEEYK TTDNDVNKK FVAWPINTKQ MVQMRRKLEM FTYLRFDMEV TFVITSRQDP GTTLAQDMPV LTHQIMYVPP GGPIPAKVDD Y AWQTSTNP ...String: GDVEEAIERA VVHVADTMRS GPSNSASVPA LTAVETGHTS QVTPSDTMQT RHVKNYHSRS ESTVENFLGR SACVYMEEYK TTDNDVNKK FVAWPINTKQ MVQMRRKLEM FTYLRFDMEV TFVITSRQDP GTTLAQDMPV LTHQIMYVPP GGPIPAKVDD Y AWQTSTNP SIFWTEGNAP ARMSIPFISI GNAYSNFYDG WSNFDQRGSY GYNTLNNLGH IYVRHVSGSS PHPITSTIRV YF KPKHTRA WVPRPPRLCQ YKKAFSVDFT PTPITDTRKD INTVTTVAQS RRRGDMSTLN TH UniProtKB: Genome polyprotein |
-Macromolecule #2: Capsid protein VP2
| Macromolecule | Name: Capsid protein VP2 / type: protein_or_peptide / ID: 2 / Number of copies: 1 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Human coxsackievirus A9 (strain Griggs) |
| Molecular weight | Theoretical: 28.885518 KDa |
| Sequence | String: SPTVEECGYS DRVRSITLGN STITTQECAN VVVGYGRWPT YLRDDEATAE DQPTQPDVAT CRFYTLDSIK WEKGSVGWWW KFPEALSDM GLFGQNMQYH YLGRAGYTIH VQCNASKFHQ GCLLVVCVPE AEMGGAVVGQ AFSATAMANG DKAYEFTSAT Q SDQTKVQT ...String: SPTVEECGYS DRVRSITLGN STITTQECAN VVVGYGRWPT YLRDDEATAE DQPTQPDVAT CRFYTLDSIK WEKGSVGWWW KFPEALSDM GLFGQNMQYH YLGRAGYTIH VQCNASKFHQ GCLLVVCVPE AEMGGAVVGQ AFSATAMANG DKAYEFTSAT Q SDQTKVQT AIHNAGMGVG VGNLTIYPHQ WINLRTNNSA TIVMPYINSV PMDNMFRHYN FTLMVIPFVK LDYADTASTY VP ITVTVAP MCAEYNGLRL AQAQ UniProtKB: Genome polyprotein |
-Macromolecule #3: Capsid protein VP3
| Macromolecule | Name: Capsid protein VP3 / type: protein_or_peptide / ID: 3 / Number of copies: 1 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Human coxsackievirus A9 (strain Griggs) |
| Molecular weight | Theoretical: 26.335072 KDa |
| Sequence | String: GLPTMNTPGS TQFLTSDDFQ SPCALPQFDV TPSMNIPGEV KNLMEIAEVD SVVPVNNVQD TTDQMEMFRI PVTINAPLQQ QVFGLRLQP GLDSVFKHTL LGEILNYYAH WSGSMKLTFV FCGSAMATGK FLIAYSPPGA NPPKTRKDAM LGTHIIWDIG L QSSCVLCV ...String: GLPTMNTPGS TQFLTSDDFQ SPCALPQFDV TPSMNIPGEV KNLMEIAEVD SVVPVNNVQD TTDQMEMFRI PVTINAPLQQ QVFGLRLQP GLDSVFKHTL LGEILNYYAH WSGSMKLTFV FCGSAMATGK FLIAYSPPGA NPPKTRKDAM LGTHIIWDIG L QSSCVLCV PWISQTHYRL VQQDEYTSAG YVTCWYQTGM IVPPGTPNSS SIMCFASACN DFSVRMLRDT PFISQDNKLQ UniProtKB: Genome polyprotein |
-Macromolecule #4: Capsid protein VP4
| Macromolecule | Name: Capsid protein VP4 / type: protein_or_peptide / ID: 4 / Number of copies: 1 / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: Human coxsackievirus A9 (strain Griggs) |
| Molecular weight | Theoretical: 7.352039 KDa |
| Sequence | String: GAQVSTQKTG AHETSLSAAG NSIIHYTNIN YYKDAASNSA NRQDFTQDPS KFTEPVKDVM IKSLPALN UniProtKB: Genome polyprotein |
-Macromolecule #5: ~{N}-[[3,4-bis(fluoranyl)phenyl]methyl]-4-[(4-methylpiperazin-1-y...
| Macromolecule | Name: ~{N}-[[3,4-bis(fluoranyl)phenyl]methyl]-4-[(4-methylpiperazin-1-yl)methyl]aniline type: ligand / ID: 5 / Number of copies: 1 / Formula: A1IEH |
|---|---|
| Molecular weight | Theoretical: 331.403 Da |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Concentration | 0.4 mg/mL |
|---|---|
| Buffer | pH: 7.2 |
| Grid | Model: Quantifoil R1.2/1.3 / Material: COPPER / Mesh: 300 / Support film - Material: CARBON / Support film - topology: CONTINUOUS / Support film - Film thickness: 2 / Pretreatment - Type: GLOW DISCHARGE / Pretreatment - Time: 10 sec. |
| Vitrification | Cryogen name: ETHANE / Chamber humidity: 85 % / Chamber temperature: 295.15 K / Instrument: LEICA EM GP Details: Sample was incubated for 15 s on the grid before blotted from the front for 1.5 s.. |
| Details | Compound 19 (CL313) was solubilized in DMSO and diluted to the final concentration in PBS + 2 mM MgCl2. Purified Coxsackievirus A9 was incubated with compound 19 (CL313) for 1h at 37C after which the sample was vitrified on a semi-automatic plunger Leica EM GP on copper Quantifoil R1.2/1.3 grids with thin carbon film and 300 mesh. This sample was monodisperse. |
-
Electron microscopy
| Microscope | FEI TALOS ARCTICA |
|---|---|
| Temperature | Min: 93.15 K / Max: 103.15 K |
| Image recording | Film or detector model: FEI FALCON III (4k x 4k) / Detector mode: COUNTING / Digitization - Dimensions - Width: 1496 pixel / Digitization - Dimensions - Height: 1496 pixel / Number grids imaged: 1 / Number real images: 630 / Average exposure time: 1.0 sec. / Average electron dose: 40.0 e/Å2 |
| Electron beam | Acceleration voltage: 200 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | Calibrated defocus max: 2.4 µm / Calibrated defocus min: 0.5 µm / Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 3.0 µm / Nominal defocus min: 0.5 µm / Nominal magnification: 150000 |
| Sample stage | Cooling holder cryogen: NITROGEN |
| Experimental equipment | ![]() Model: Talos Arctica / Image courtesy: FEI Company |
Movie
Controller
About Yorodumi




Coxsackievirus A9
Keywords
Authors
Finland, 3 items
Citation

















Z (Sec.)
Y (Row.)
X (Col.)




































Homo sapiens (human)
Processing
FIELD EMISSION GUN


